Part 3 of our multi-part series takes us to how intellectual property is treated in scientific disciplines, particularly chemistry (pharmaceuticals) and biology (biotech). He take a look at the high-stakes business of drug development, weigh the ethical considerations of patenting biotechnology, and more. Plus we also talk discuss Trademark Law, in light of the recent "Dumb Starbucks" controversy that has swept up Twitter.
